Fairtree Asset Management Pty Ltd Acquires 1,221 Shares of HCA Healthcare, Inc. $HCA

Fairtree Asset Management Pty Ltd lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 69.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,975 shares of the company’s stock after acquiring an additional 1,221 shares during the quarter. Fairtree Asset Management Pty Ltd’s holdings in HCA Healthcare were worth $1,268,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Clearstead Trust LLC increased its holdings in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. increased its stake in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $40,000. Compound Global Advisors LLC bought a new stake in HCA Healthcare in the third quarter valued at approximately $44,000. Finally, True Wealth Design LLC increased its holdings in shares of HCA Healthcare by 179.5% during the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last 90 days. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Up 0.5%

NYSE:HCA opened at $528.69 on Monday. The firm has a market capitalization of $118.23 billion, a PE ratio of 18.63, a price-to-earnings-growth ratio of 1.63 and a beta of 1.34. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $552.90. The stock’s 50-day simple moving average is $493.99 and its 200 day simple moving average is $460.92.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. The Goldman Sachs Group upped their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Robert W. Baird increased their price target on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. UBS Group upped their price objective on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Finally, Zacks Research downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $534.50.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.